Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Frequently asked questions

Here are some of the most common questions about phage, phage therapy and antimicrobial resistance (AMR).

Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis.

Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis Abstact Rationale: Neutrophils are

Air trapping in early cystic fibrosis lung disease—Does CT tell the full story?

Air trapping in early cystic fibrosis lung disease—Does CT tell the full story? Abstract Introduction: Mosaic attenuation on expiratory chest

Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review

Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review ABSTRACT Introduction: Lung disease in cystic fibrosis begins

Asthma

Respiratory disease is a global issue and international networks are critical to informing best-practice approaches to the clinical care and management of childhood respiratory health.

Cystic Fibrosis

Cystic fibrosis (CF) is the most common life‐shortening genetic disease affecting children.

Clinical Trials, Platforms & Cohorts

Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.

Expertise and technologies

The Respiratory Physiology Platform at the Wal-yan Respiratory Research Centre offers access to specialist equipment housed within the outpatient research department at Perth Children’s Hospital, dedicated for research use.